(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IOVANCE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IOVANCE

ST13

US500000087476198

Class

1, 5, 44

Filing

87476198

Registration

6479209

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

67

Latest update

04/09/2026

Trademark type

Word

Nice classes

1, 5, 44

Filing date

06/05/2017

Registration date

09/07/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/07/2021

Last transaction

04/09/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/24/2021

First use in commerce

02/24/2021

Drawing code

4

Owner type

03

Owner location

SAN CARLOS, CA, US

Examiner

HOWARD, PARKER WALDRIP

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

IOVANCE BIOTHERAPEUTICS, INC.
Lion Biotechnologies, Inc

Representatives

Carla B. Oakley MORGAN, LEWIS & BOCKIUS LLP

Technical classification

Nice Classes

Class 1Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

cells for cancer treatment research; chemical preparations for use in clinical research; biological tissueshuman cells for use in scientific and medical research

Class 5

pharmaceuticals for the treatment of oncological disease and disorders; pharmaceutical preparations for use in immunotherapy for the treatment of oncological disease and disorders

Class 44

medical servicesmodifying cells for the treatment of cancer and other diseases and medical conditions; immunotherapy treatments; medical diagnostic and treatment services; providing information in the field of oncology and immunotherapy treatments; providing medical informationconsultancy and advisory services

Publications

History of USPTO decisions and trademark events.

67 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/07/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/07/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/07/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/23/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/23/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/23/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/23/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/23/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

09/07/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/05/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/04/2021

DOCK

ASSIGNED TO EXAMINER

07/20/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/06/2021

IUAF

USE AMENDMENT FILED

03/03/2021

EISU

TEAS STATEMENT OF USE RECEIVED

03/03/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/16/2020

EX5G

SOU EXTENSION 5 GRANTED

09/15/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/15/2020

EXT5

SOU EXTENSION 5 FILED

09/04/2020

EEXT

SOU TEAS EXTENSION RECEIVED

09/04/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/07/2020

EX4G

SOU EXTENSION 4 GRANTED

03/05/2020

EXT4

SOU EXTENSION 4 FILED

03/05/2020

EEXT

SOU TEAS EXTENSION RECEIVED

03/05/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/07/2019

EX3G

SOU EXTENSION 3 GRANTED

09/05/2019

EXT3

SOU EXTENSION 3 FILED

09/05/2019

EEXT

SOU TEAS EXTENSION RECEIVED

09/05/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/08/2019

EX2G

SOU EXTENSION 2 GRANTED

03/06/2019

EXT2

SOU EXTENSION 2 FILED

03/06/2019

EEXT

SOU TEAS EXTENSION RECEIVED

03/06/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/07/2018

EX1G

SOU EXTENSION 1 GRANTED

09/05/2018

EXT1

SOU EXTENSION 1 FILED

09/05/2018

EEXT

SOU TEAS EXTENSION RECEIVED

09/05/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/06/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/09/2018

PUBO

PUBLISHED FOR OPPOSITION

01/09/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/20/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/04/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

12/04/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/01/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

12/01/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/01/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

11/29/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/28/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

11/28/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/28/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

11/28/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/27/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

11/27/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/27/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/04/2017

GNRT

NON-FINAL ACTION E-MAILED

10/04/2017

CNRT

NON-FINAL ACTION WRITTEN

10/04/2017

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/27/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/15/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/15/2017

ALIE

ASSIGNED TO LIE

09/13/2017

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

09/06/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/02/2017

GNRT

NON-FINAL ACTION E-MAILED

09/02/2017

CNRT

NON-FINAL ACTION WRITTEN

09/02/2017

DOCK

ASSIGNED TO EXAMINER

09/02/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/12/2017

NWAP

NEW APPLICATION ENTERED

06/08/2017

Continuous trademark protection

Get notified about every new filing that threatens IOVANCE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.